Hydromorphone HCl Polymorphs Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current forms of hydromorphone hydrochloride (HCl) have limitations in terms of purity and stability, which can affect their pharmacological efficacy and administration, particularly for severe pain management.

Innovation Solution

Development of four novel forms of hydromorphone HCl (Forms B, C, D, and an amorphous form) characterized by unique X-ray powder diffraction patterns and thermal properties, which can be produced and used in combination with the known form (Form A) to enhance therapeutic effects and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If known form (Form A) of hydromorphone HCl is used, then commercial availability and established administration routes are ensured, but purity and stability are limited

Engineering Contradiction:
ImprovestabilityVSAvoidpharmaceutical formulation options
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by discovering and utilizing different polymorphic forms (Forms B, C, D, and amorphous) of hydromorphone HCl, each with distinct crystal structures and physical properties. These polymorphic variations enable improved stability and diverse pharmaceutical formulation options while maintaining the core analgesic functionality of the compound.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If novel polymorphic forms (Forms B, C, D, amorphous) are developed, then purity and stability are improved, but manufacturing complexity increases

Engineering Contradiction:
ImprovepurityVSAvoidmanufacturing process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent utilizes phase transitions by employing specific crystallization conditions and solvent systems to transform hydromorphone HCl into desired polymorphic forms. The manufacturing processes involve controlled phase transitions from solution or melt states to specific crystal structures (Forms B, C, D) or amorphous states, enabling purification and stability enhancement through deliberate phase change management.

Inventive Principle:
Principle #36Phase transitions

Data Source

PatentUS7550592B2Hydromorphone polymorphs
Publication Date: 2009.06.23 NORAMCO LLC
  • US7550592B2 patent drawing
  • US7550592B2 patent drawing
  • US7550592B2 patent drawing

AI summary

Hydromorphone hydrochloride forms are disclosed which are useful as analgesic agents either in combination with or as replacements for hydromorphone hydrochloride.